INEOS Styrolution to display innovative styrenic healthcare solutions at MD&M West 2023 in Anaheim, California
Aurora, Ill, USA
- Learn about one of the most comprehensive resin portfolios used in medical design
- Meet material experts to discuss innovative and sustainable styrenic solutions for healthcare
INEOS Styrolution, the global leader in styrenics, will highlight its product expertise in styrenic solutions for the healthcare industry at “the world's largest medical design and manufacturing event”, MD&M West 2023. Showing in booth #1337, February 7-9, 2023 at the Anaheim Convention Center in Anaheim, California. The company’s experts will discuss innovative styrenic solutions for the healthcare industry.
INEOS Styrolution offers a comprehensive selection of styrenic materials ideal for use in a wide-range of applications and robust regulatory and technical support. Material resin experts and skilled specialists’ knowledgeable in specific medical applications and regulations, will be available to show their wide-reaching proficiency of the medical industry and highlight their support for stakeholders in the healthcare sector at MD&M West 2023
“With our large portfolio of healthcare resins, our exceptional technical service, and our outstanding regulatory support, we have positioned ourselves as a premier resin supplier to the healthcare industry. We’ve successfully partnered with many medical device manufacturers to bring innovative solutions to the industry,” says Alexander Silvestre, Global Director, Healthcare, INEOS Styrolution.
Product focus at MD&M West 2023 includes; Lustran® 348 for inhaler housings, auto-injectors and various drug delivery opaque applications, Lustran® SAN for specialty diagnostic and labware applications, Styrolux® for fluid containers and IV set components, and K-Resin® for filters and respiratory devices.
INEOS Styrolution has made a strong commitment to supporting sustainability objectives and a plastics circular economy. Efforts are underway to implement a number of new programs such as use of bio-attributable feedstocks. The company announced the availability of their first ECO healthcare grade Novodur® ECO B in August of 2022. Mass balance based, bio-circular Novodur ECO HD M203 FC B50 offers a 50% contribution of bio-attributed content and has been designed specifically for electroplating making it a material of choice for various hygienic applications for the medical industry.
The company invites MD&M West 2023 show attendees to meet with their technical experts in booth #1337 and learn more about the capabilities of their healthcare resins for the safe development of medical applications.